Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1983-07-19
1985-05-21
Roberts, Elbert L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514866, A61K 3156
Patent
active
045185956
ABSTRACT:
Diabetes is treated by orally administering a dehydroepiandrosterone (DHEA) compound selected from the group consisting of DHEA, DHEA sulfate and soluble DHEA compounds. The DHEA compound is preferably administered in finely dispersed form, powdered or solution, mixed with the food diet of the diabetic in a dosage range of up to 0.4% by weight of the food diet. The pharmacological activity and utility of DHEA as a potent anti-diabetic agent and anti-hyperglycemic agent over a variable range of genetic background is documented.
REFERENCES:
Coleman et al., "Diabetes", vol. 31, Sep. 1982, pp. 830-833.
Applezweig Norman
Coleman Douglas L.
Leiter Edward H.
Kane, Jr. Daniel H.
Roberts Elbert L.
The Jackson Laboratory
LandOfFree
Method for treating diabetes using DHEA compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating diabetes using DHEA compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating diabetes using DHEA compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1537791